Targeted therapy for lung cancer: Beyond EGFR and ALK. Herrera-Juarez M, Serrano-Gomez C, Bote-de-Cabo H, Paz-Ares L, et al. Cancer 2023 Apr 19. doi: 10.1002/cncr.34757.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Herrera-Juarez M, Serrano-Gomez C, Bote-de-Cabo H, Paz-Ares L, et al. Targeted therapy for lung cancer: Beyond EGFR and ALK. Cancer 2023 Apr 19. doi: 10.1002/cncr.34757.
PMID: 37073562